Friday, August 17, 2018

Teva up 7.3% after FDA approves their new generic Epipen

TEVA - Pharmaceutical Industries Limited just released a generic Epipen approved by the FDA - bringing competition to the emergency allergy treatment.
I'm not sure if I should buy the stock, since it seems to have been very unstable over the past few months.
What would you guys do?



Submitted August 17, 2018 at 03:59AM by Accent_Your_Comment https://ift.tt/2L5EwNW

No comments:

Post a Comment